The request for offers is carried out with the reference to the application process for the grant titled:
SOE: First breakthrough therapy for sarcoidosis
as part of the 1/1.1.1/2019 SEAL OF EXCELLENCE contest, Priority I: Support for conducting R&D works by enterprises, Sub-measure 1.1.1. Industrial research and development works carried out by enterprises co-financed by the European Union Funds and because of the competitiveness principle.
Execution of the chronic toxicity studies on animals work package for the chitinase inhibitor, OATD-01, developed as first breakthrough therapy for sarcoidosis